Martin Lynn C 4
4 · Intercontinental Exchange, Inc. · Filed Jul 20, 2026
Research Summary
AI-generated summary of this filing
ICE President Lynn C. Martin Exercises Options, Sells 15,882 Shares
What Happened
- Lynn C. Martin, President of the NYSE Group at Intercontinental Exchange, exercised 15,882 stock options at $57.31 per share (cost $910,197) on July 16, 2026, and sold the same 15,882 shares in open-market transactions that generated aggregate gross proceeds of $2,241,714. The net cash before fees and taxes was roughly $1.33M (proceeds minus exercise cost). This pattern (exercise followed by sale) is a routine monetization of vested options rather than a new share purchase.
Key Details
- Transaction date: July 16, 2026.
- Exercise: 15,882 shares at $57.31 per share (total cost $910,197); options are fully vested (Footnote F10).
- Sales: 15,882 shares sold across multiple trades at prices ranging roughly $139.75–$142.30 (aggregate proceeds $2,241,714; see F3–F6 for price-range breakdowns).
- Beneficial ownership after transaction (per filing notes): the reported holdings represent 41,499 shares of common stock plus 9,805 unvested RSUs and 3,116 PSUs (performance period satisfied for those PSUs) — see Footnote F7. The beneficial-ownership total also includes 101 shares acquired under the company ESPP on 6/30/2026 (F2).
- Trading plan: sales were effected pursuant to a Rule 10b5-1 trading plan effective May 29, 2025 (F1).
- Filing timeliness: no late filing flag indicated.
Context
- This was effectively a same-day exercise-and-sell (often called a cashless exercise/net sale): Martin exercised vested options and sold the resulting shares. The filing also shows a derivative-related disposition at $0.00 (common in option settlements or net share settlement for tax/withholding). The sale was executed under a pre-established 10b5-1 plan, which is designed to allow programmed trading while limiting potential claims of opportunistic insider timing.
Insider Transaction Report
Form 4
Martin Lynn C
President, NYSE Group
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-07-16$57.31/sh+15,882$910,197→ 70,302 total - Sale
Common Stock
[F1][F3]2026-07-16$139.75/sh−3,000$419,237→ 67,302 total - Sale
Common Stock
[F1][F4]2026-07-16$140.90/sh−3,200$450,892→ 64,102 total - Sale
Common Stock
[F1][F5]2026-07-16$141.65/sh−9,482$1,343,125→ 54,620 total - Sale
Common Stock
[F1][F6][F7][F8][F9]2026-07-16$142.30/sh−200$28,460→ 54,420 total - Exercise/Conversion
Employee Stock Option (right to buy) Holding
[F10]2026-07-16−15,882→ 0 totalExercise: $57.31Exp: 2027-01-18→ Common Stock (15,882 underlying)
Footnotes (10)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025.
- [F10]These options are fully vested.
- [F2]Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
- [F3]The price range for the aggregate amount sold by the direct holder is $139.23 - $140.18. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- [F4]The price range for the aggregate amount sold by the direct holder is $140.26 - $141.23. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- [F5]The price range for the aggregate amount sold by the direct holder is $141.27 - $142.22. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- [F6]The price range for the aggregate amount sold by the direct holder is $142.30 - $142.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- [F7]The common stock number referred in Table I is an aggregate number and represents 41,499 shares of common stock and 9,805 unvested restricted stock units ("RSUs"), and 3,116 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
- [F8]The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
- [F9]The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Signature
/s/ Octavia N. Spencer, Attorney-in-fact|2026-07-20